As Manufacturers Rush, Children With Co-Morbidities on Priority List of Centre’s Vaccination Plan: Report

By
-
0
232

In September 2020, Novavax announced a manufacturing agreement with SII for its COVID-19 vaccine NVX-CoV2373.